Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mfglola's Profile
Displaying 51-100 of 119 result(s).
CYDY CytoDyn Inc
04/10/2025 7:36:14 PM
If not, are there other types of br (2)
CYDY CytoDyn Inc
03/26/2025 9:46:30 AM
The trial you linked must have used (2)
CYDY CytoDyn Inc
03/13/2025 10:08:08 AM
The hidden scars of ulcerative coli (10)
CYDY CytoDyn Inc
02/27/2025 3:53:01 PM
I see Dr. P will be on Steve Kirsch (4)
CYDY CytoDyn Inc
02/22/2025 5:54:11 PM
A discovery at Duke-NUS Medical Sch (14)
CYDY CytoDyn Inc
02/12/2025 11:01:01 PM
maraviroc is now a generic drug , n
CYDY CytoDyn Inc
01/27/2025 8:59:51 PM
I haven't ran across any studies lo (8)
CYDY CytoDyn Inc
01/27/2025 8:32:33 AM
Agenus' botensilimab/balstilimab co (4)
CYDY CytoDyn Inc
01/10/2025 8:39:05 AM
Mediar Therapeutics Enters into Glo (7)
CYDY CytoDyn Inc
01/08/2025 6:16:03 PM
Calico’s fosigotifator was tested (4)
CYDY CytoDyn Inc
12/15/2024 1:39:02 PM
Maybe I missed it, but I don't reme (3)
CYDY CytoDyn Inc
12/12/2024 7:41:59 PM
I'm sure he's very aware of the sto (3)
CYDY CytoDyn Inc
12/09/2024 8:45:57 AM
And playing six degrees of leronlim (8)
CYDY CytoDyn Inc
12/06/2024 8:09:36 PM
Maybe it is the Gates Foundation th (14)
CYDY CytoDyn Inc
11/22/2024 3:39:58 PM
The dosing schedule should be and t (2)
CYDY CytoDyn Inc
11/14/2024 11:26:32 PM
I think someone (Ohm?) should make (3)
CYDY CytoDyn Inc
11/13/2024 2:34:34 PM
Upregulation of CCL4 after treatmen (6)
CYDY CytoDyn Inc
11/05/2024 6:59:00 AM
Surrogate reads like anecdotal is b (4)
CYDY CytoDyn Inc
10/31/2024 9:07:29 PM
HOW are they able to showcase "slow (6)
CYDY CytoDyn Inc
10/31/2024 11:20:29 AM
What is a bit strange is that they (1)
CYDY CytoDyn Inc
10/30/2024 8:40:24 AM
Familial ALS? I'm so sorry. That mu (3)
CYDY CytoDyn Inc
10/30/2024 7:01:05 AM
Coya yesterday reported their low d (2)
CYDY CytoDyn Inc
10/29/2024 8:36:20 PM
I would expect academic institution (7)
CYDY CytoDyn Inc
10/29/2024 10:54:47 AM
Ohm - do you discount the possibili (4)
CYDY CytoDyn Inc
10/28/2024 8:19:27 AM
At a townhall in Lancaster PA, Elon (13)
CYDY CytoDyn Inc
10/19/2024 6:16:10 PM
A fascinating conversation on ccr5 (6)
CYDY CytoDyn Inc
10/11/2024 12:33:51 PM
Findings may guide future Parkinson (5)
CYDY CytoDyn Inc
10/06/2024 2:11:04 PM
Since it is an open label study, it (6)
CYDY CytoDyn Inc
09/29/2024 8:34:15 AM
Interesting connection between two (4)
CYDY CytoDyn Inc
09/26/2024 6:05:26 PM
Pegozafermin received BTD for MASH (4)
CYDY CytoDyn Inc
09/24/2024 11:10:02 PM
The publication shows that 76% of p (3)
CYDY CytoDyn Inc
09/24/2024 10:38:32 PM
No, US FDA BTD. https://inventivaph
CYDY CytoDyn Inc
09/24/2024 9:23:55 PM
Lanifibranor received BTD for these (3)
CYDY CytoDyn Inc
09/22/2024 6:25:46 PM
So it's a bit counter-intuitive to (7)
CYDY CytoDyn Inc
09/12/2024 9:00:54 PM
The PI of the trial, with hindsight (1)
CYDY CytoDyn Inc
09/11/2024 7:38:25 PM
Stem cells in heart failure with re (4)
CYDY CytoDyn Inc
09/09/2024 9:16:21 AM
the Pennsylvania Cancer and Regene (4)
CYDY CytoDyn Inc
08/29/2024 4:19:13 PM
Indeed. Even mainstream media picke (4)
CYDY CytoDyn Inc
08/28/2024 8:28:07 AM
Restoring hippocampal glucose metab (9)
CYDY CytoDyn Inc
08/26/2024 7:13:09 PM
I expect FDA would be interested in (4)
CYDY CytoDyn Inc
08/23/2024 11:27:50 PM
On a few conference calls, Dr. Reck (3)
CYDY CytoDyn Inc
08/23/2024 9:37:05 PM
Dr. Recknor had identified Syneos a (3)
CYDY CytoDyn Inc
08/20/2024 2:20:39 PM
Coya Therapeutics has low dose IL-2 (2)
CYDY CytoDyn Inc
08/14/2024 9:02:23 AM
Accelerated approval is very much a (19)
CYDY CytoDyn Inc
08/13/2024 4:20:25 PM
Thanks. I suppose that is good for (4)
CYDY CytoDyn Inc
08/13/2024 11:34:21 AM
The phase 3 trial of Trifluridine/â (4)
CYDY CytoDyn Inc
07/19/2024 11:38:19 AM
Seems FDA nixed Agenus' plan for ac (3)
CYDY CytoDyn Inc
07/11/2024 8:49:11 PM
After our preclinical glioblastoma (3)
CYDY CytoDyn Inc
07/08/2024 4:24:23 PM
I think that study was focused on p (1)
CYDY CytoDyn Inc
07/08/2024 8:13:36 AM
Will be interesting to see what kin (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Sunrise New Energy Secures $30 Million Supply Deal for Growth
  • The Impressive Growth of Booking Holdings Stock Unveiled
  • Exploring the Legal Investigation Into Humana, Inc. (NYSE:HUM)
  • Investors of Perrigo Company plc Should Act Before Class Action Deadline
  • Exploring a New Paradigm: Evolution in the Age of AI
  • Long-Term Investment Insights: CACI International's Growth Journey
  • Snowflake Stock Soars Amid Strong Earnings Expectations
  • Investigation into Securities Violations of Jayud Global Logistics
  • Understanding the Skye Bioscience Class Action Lawsuit
  • Asetek Ramps Up Transparency with Major Insider Trade
  • TVA Secures Significant Grant to Propel Nuclear Innovations
  • Exploring the Impact of Venezuela's Oil Revival on Inflation Trends
  • Protest Highlights Concerns Over AI Regulation and Child Safety
  • Sunrise New Energy Expands into Energy Storage with New Contract
  • Investigation of Varonis Systems: Legal Actions and Financial Insights
  • Jayud Global Logistics Ltd. Encourages Shareholder Awareness
  • Bringing Together Leaders for a Sustainable Financial Future
  • Transformative Energy Efficiency Approvals Enhance Innovations
  • Kofile Technologies Reveals Kleio: A Game Changer for Agencies
  • Global Leaders Unite for Sustainable Capital Mobilization Efforts
  • Understanding the DeFi Technologies Inc. Class Action Case
  • Important Update for WPP Investors Regarding Class Action Suit
  • Primo Brands Corporation Shareholders: Legal Class Action Update
  • BEC Technologies Launches Enhanced MX-220 5G Router Series
  • Celebrate Christmas: 53rd Annual North End Parade Event
  • Crypto Market Sees Major Gains Driven by Institutional Interest
  • Important Update for Freeport-McMoRan Investors Amid Legal Action
  • Intel's Journey: Navigating Market Trends and Future Growth
  • Ondas Holdings Stock Sees Surge Amid New Contracts and Appointments
  • Universal Synaptics Partners with GGAS to Enhance Aviation Training
  • Kooth Strengthens Impact on Youth Mental Health with Kismet
  • Understanding Baker Hughes' Stock Performance and P/E Ratio Insights
  • Exploring Recent Trends in FedEx's Options Market Activity
  • Warner Bros. Discovery's Options Activity: Insights Revealed
  • Understanding Recent Trends in Intel's Options Activity
  • Michael Saylor's Bitcoin Decision Sparks Market Volatility
  • JLAM Introduces Pinevale: A New Standard for Affordable Living
  • Vanguard's Groundbreaking Shift in Cryptocurrency ETF Access
  • How AI Will Revolutionize Online Shopping Why These ETFs Matter
  • Understanding Market Trends and Short Interest in Ally Financial
  • Investing in Boston Scientific: A Journey Over Five Years
  • Jazz Pharmaceuticals PLC: Insights Into Current Short Interest Trends
  • Understanding Recent Market Trends for Check Point Software
  • Unlocking Long-Term Wealth: The Rise of Intercontinental Exchange
  • Michael Burry's Bearish Insights on Market Dynamics
  • Critical Foot Care Initiative by Forté Orthopedic and Colts
  • OneTrust Recognized as Leader in Privacy Management Software
  • StockX Achieves Remarkable Growth This Holiday Shopping Season
  • Brand Engagement Network's Game-Changing Reverse Stock Split
  • Sun Auto Tire & Service Contributes $50,000 to Komen Efforts
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site